De Novo design of a humanized antiCD33 antibody-oridonin conjugate for acute myeloid leukemia therapy. Feng H, Liu Y, Zhang M, Liu R, et al. Biochem Biophys Res Commun 2022;629:152-158.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Feng H, Liu Y, Zhang M, Liu R, et al. De Novo design of a humanized antiCD33 antibody-oridonin conjugate for acute myeloid leukemia therapy. Biochem Biophys Res Commun 2022;629:152-158.
PMID: 36122452